Amphastar Pharmaceuticals, Inc. stock price

Amphastar Pharmaceuticals, Inc. latest news:

  • 08/09/2017 14:52:49

    BRIEF-Amphastar Pharmaceuticals reports Q2 earnings per share $0.04

    Amphastar Pharmaceuticals Inc(AMPH)- * Amphastar Pharmaceuticals(AMPH) reports financial results for the three months ended june 30, 2017. * Q2 adjusted non-gaap earnings per share $0.11. * Q2 gaap earnings per share $0.04. * Q2 revenue $65.2 million versus I/B/E/S view $63.3 million.

  • 07/21/2017 10:42:14

    U.S. jury sides with Amphastar over Momenta in drug patent trial

    Amphastar Pharmaceuticals Inc(AMPH) on Friday won a trial in a lawsuit claiming that the drugmaker through its production of a generic version of the blood-thinner Lovenox infringed a patent held by Momenta Pharmaceuticals Inc. The verdict by a federal jury in Boston came in a long-running lawsuit pursued by Cambridge, Massachusetts-based biopharmaceutical company Momenta and its partner, Novartis AG...

  • More trends:

    Amsurg Corp.AMSG | Amsurg Corp.AMSGP | Amtech Systems, Inc.ASYS | AmTrust Financial Services, Inc.AFSI | Amyris, Inc.AMRS | Anacor Pharmaceuticals, Inc.ANAC | ANADIGICS, Inc.ANAD | Analog Devices, Inc.ADI | Analogic CorporationALOG | Anchor BancorpANCB |